MYD88 and breast cancer: As we show in glioblastoma, IL-1β initiates a cascade of events similar to that in aggressive luminal-type breast cancer cell where mRNA and protein levels of MyD88 induce and activate NFĸB, which in turn activates IL-6 [25] for activation of Calcineurin [26].